. . . . . . . . . "Amobarbital sodium is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident." . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "LJQDayrKILHa5CJKQjm81DhHS7M8KDKpvpvSQYY8d/JuArJQcrzGoR3Fwvpp5Al3JlqI0FMZZFQ84+wzQiijK8M3WvGaUOOh8xNhFI4lFz25bR7hJw2zyyTk7iFg7bs+VQCljk84jPJ/vHObU1D5h8Wu8so7xt3eN6zCKW+5itc=" . . "2021-08-25T14:39:32.083+02:00"^^ . . . . .